HCP
56
-8
SLB
52
-3
MLM
45
-5
HSIC
45
5
AN
50
-5
STZ
52
-6
MCO
71
-7
HSY
31
-6
ZTS
47
2
TJX
62
-2
EOG
56
-2
GE
61
-3
SRE
63
2
V
64
-2
AMT
37
3
ISRG
71
-5
IR
63
-3
FOX
51
-6
COP
57
-2
UNH
57
-2
HCP
56
-8
SLB
52
-3
MLM
45
-5
HSIC
45
5
AN
50
-5
STZ
52
-6
MCO
71
-7
HSY
31
-6
ZTS
47
2
TJX
62
-2
EOG
56
-2
GE
61
-3
SRE
63
2
V
64
-2
AMT
37
3
ISRG
71
-5
IR
63
-3
FOX
51
-6
COP
57
-2
UNH
57
-2
Financhill
Back

Direxion HCM Tactical EnhU.S.EqStratETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
45

HCMT
Direxion HCM Tactical EnhU.S.EqStratETF

Last Price:
36.04
Seasonality Move:
26.23%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
45
Direxion HCM Tactical EnhU.S.EqStratETF (HCMT) is a Sell

Is Direxion HCM Tactical EnhU.S.EqStratETF a Buy, Sell or Hold?

  • The current Direxion HCM Tactical EnhU.S.EqStratETF [HCMT] share price is $36.09. The Score for HCMT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • HCMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HCMT Stock Price Chart

What is Direxion HCM Tactical EnhU.S.EqStratETF's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HCMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 48.61 Sell
Chaikin Money Flow: -22624 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.26 - 37.38) Sell
Bollinger Bands (100): (32.33 - 36.29) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HCMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.57 Sell
20-day SMA: 36.38 Sell
50-day SMA: 35.33 Buy
200-day SMA: 32.37 Buy
8-day EMA: 37.07 Sell
20-day EMA: 36.55 Sell
50-day EMA: 35.53 Buy
200-day EMA: 32.35 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Direxion HCM Tactical EnhU.S.EqStratETF Earnings Growth & HCMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Direxion HCM Tactical EnhU.S.EqStratETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):